You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Denileukin diftitox

Showing 1 - 25 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma Trial in Louisville (Ipilimumab)

Terminated
Has Results
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 22, 2021

Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma

Recruiting
  • Lymphoma, T-cell, Peripheral
  • Lymphoma, T-cell, Cutaneous
  • Nagoya, Japan
  • +2 more
Nov 24, 2022

GVHD, Immune System Disorders Trial in United States (Etanercept, Mycophenolate Mofetil, Denileukin Diftitox)

Completed
Has Results
  • Graft vs Host Disease
  • Immune System Disorders
  • Duarte, California
  • +18 more
Oct 19, 2021

Peripheral T-Cell Lymphoma Trial in Saint Louis (Gemcitabine, Navelbine, Doxorubicin Hydrochloride Liposome Injection)

Terminated
Has Results
  • Peripheral T-Cell Lymphoma
  • Saint Louis, Missouri
    Washington University
Apr 14, 2020

Leukemia, Adult T-Cell Trial run by the NCI (Denileukin diftitox (Ontak))

Terminated
Has Results
  • Leukemia, Adult T-Cell
  • Denileukin diftitox (Ontak)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 8, 2019

Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 4, 2022

Stage IIIC Melanoma, Stage IV Melanoma Trial in United States (Denileukin diftitox)

Completed
  • Stage IIIC Melanoma
  • Stage IV Melanoma
  • Denileukin diftitox
  • Encinitas, California
  • +9 more
Feb 28, 2019

Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Seattle (biological,

Completed
  • Fallopian Tube Cancer
  • +10 more
  • denileukin diftitox
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 13, 2019

Multiple Myeloma Trial in Duarte, Boston, Portland (SL-401/ Pomalidomide/ Dexamethasone)

Terminated
  • Multiple Myeloma
  • SL-401/ Pomalidomide/ Dexamethasone
  • Duarte, California
  • +2 more
Jan 13, 2022

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Seattle (biological, other, genetic)

Completed
Has Results
  • Male Breast Cancer
  • +5 more
  • ONTAK
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018

Peripheral T-Cell Lymphoma Trial in Japan (denileukin diftitox (E7777))

Completed
Has Results
  • Peripheral T-Cell Lymphoma
  • denileukin diftitox (E7777)
  • Nagoya, Aichi, Japan
  • +3 more
Apr 22, 2018

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Graft-versus-Host Disease, Immune System Disorders Trial in United States (Mycophenolate Mofetil, Placebo)

Completed
Has Results
  • Graft-versus-Host Disease
  • Immune System Disorders
  • Mycophenolate Mofetil
  • Placebo
  • Duarte, California
  • +35 more
Dec 7, 2022

Epithelial Ovarian Cancer, Extraovarian Peritoneal Cancer, Fallopian Tube Carcinoma Trial in San Antonio (Denileukin Diftitox/SC

Terminated
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • Denileukin Diftitox/SC Pegylated IFNα-2a
  • San Antonio, Texas
    CTRC (Cancer Therapy and Research Center) at UTHSCSA
Mar 13, 2018

Epithelial Ovarian Cancer, Extraovarian Peritoneal Cancer, Fallopian Tube Carcinoma Trial in San Antonio (Ontak)

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • San Antonio, Texas
    CTRC at UTHSCSA
Feb 27, 2018

Melanoma Trial in Chicago (4-peptide melanoma vaccine, Ontak)

Terminated
Has Results
  • Melanoma
  • 4-peptide melanoma vaccine
  • Ontak
  • Chicago, Illinois
    University of Chicago
Jan 6, 2021

Leukemia, Myelogenous, Acute Trial in Minneapolis (biological, drug, procedure)

Terminated
Has Results
  • Leukemia, Myelogenous, Acute
  • Natural Killer Cells
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Multiple Myeloma Trial in Detroit (Denileukin Diftitox (Ontak))

Terminated
Has Results
  • Multiple Myeloma
  • Denileukin Diftitox (Ontak)
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 26, 2017

Non-infectious Intermediate and Posterior Uveitis Trial run by the NEI (Daclizumab)

Completed
  • Non-infectious Intermediate and Posterior Uveitis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Melanoma (Skin) Trial in Erlangen (Dendritic cell vaccine plus denileukin difitox)

Completed
  • Melanoma (Skin)
  • Dendritic cell vaccine plus denileukin difitox
  • Erlangen, Germany
    Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Er
Feb 16, 2018

Leukemia Trial in United States (denileukin diftitox)

Completed
  • Leukemia
  • denileukin diftitox
  • Orange, California
  • +10 more
Jan 17, 2017

Lymphoma Trial in Miami (biological, drug, genetic, other)

Withdrawn
  • Lymphoma
  • denileukin diftitox
  • +10 more
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center - Miam
Dec 14, 2016

Metastatic Pancreatic Cancer Trial in Maywood (Ontak)

Terminated
Has Results
  • Metastatic Pancreatic Cancer
  • Maywood, Illinois
    Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Cent
Aug 23, 2016

Lymphoma Trial in United States (denileukin diftitox, rituximab)

Completed
Has Results
  • Lymphoma
  • denileukin diftitox
  • rituximab
  • Scottsdale, Arizona
  • +164 more
Mar 7, 2017

GVHD Trial in Rawalpindi (Mesenchymal Stem Cells)

Completed
  • Graft Versus Host Disease
  • Mesenchymal Stem Cells
  • Rawalpindi, Punjab, Pakistan
    Armed Forces Bone Marrow Transplant Centre
Jan 24, 2017